Tuberculous Pericarditis, Two Case Report
Main Article Content
Abstract
Background: Mycobacterium tuberculosis is among the leading causes of death, usually in underdeveloped countries, being the state of Baja California with most cases and deaths in Mexico. This infection can affect pericardium, although infrequent and it represents 1-4% of the cases of tuberculosis. The relevance of this presentation is the difficulty of diagnosis and high mortality.
Objective: Demonstrate the importance of keeping the high suspicion that this type of tuberculosis in endemic entities because of high mortality and the existence of treatment.
Description Of The Cases: 39 year old male who practiced sex with men and had multiple comorbidities. Referred to the emergency department to start antituberculous treatment. During his stay he presented deterioration of health. Pericardiocentesis was performed with results suggestive of Mycobacterium tuberculosis. He subsequently presents cardio respiratory arrest without spontaneous return of the circulation. The second case it’s about a 69 year old male who came into the emergency room with lower respiratory tract infection symptoms with two months of evolution and signs of cardiac insufficiency. An echocardiogram was performed meeting pericardial effusion which confirms the etiology of tuberculosis and started an antituberculous treatment with good evolution until discharge.
Conclusion: Currently, in endemic zones of Mycobacterium tuberculosis is important to suspect this agent in view of typical presentation of infection and atypical presentation of frequent pathologies.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. López‐López JP, Posada‐Martínez EL, Saldarriaga C, Wyss F, Ponte‐Negretti CI, Alexander B, et al. Tuberculosis and the Heart. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. March 18, 2021;10(7):1–10.
II. Barba Evia Jose Roberto. Tuberculosis. ¿Es la pandemia ignorada? Rev Mex Patol Clínica Med Lab. September 23, 2020;67(2):93–112.
III. Salud S de. Tuberculosis [Internet]. gob.mx. 2016 [citado el 11 de mayo de 2023]. Available in: http://www.gob.mx/salud/acciones-y-programas/tuberculosis
IV. Ceballos Elizabeth, Garcia Gabirel, LopezYanet, Rojas Nilza, Uriel Jonathan, Zaragoza Christian. Boletin epidemiologico Sistema Nacional de Vigilancia Epidemiologica Sistema Unico de Informacion. Secretaria de la salud; 2023.
V. Dybowska M, Błasińska K, Gątarek J, Klatt M, Augustynowicz-Kopeć E, Tomkowski W, et al. Tuberculous Pericarditis—Own Experiences and Recent Recommendations. Diagnostics. March 2, 2022;12(3):619.
VI. Lagoeiro Jorge1 AJ, de Andrade Martins1 W, Batista da Costa2 WL, Kiyomura Rosslli3 A, Chaves Ferreira Coelho3 L, Shinji Nobre Soussume3 W. Pericarditis constrictiva por tuberculosis, una condición de difícil diagnóstico. Insufic Cardíaca. June 2018;13(2):97–100.
VII. Chang SA. Tuberculous and Infectious Pericarditis. Cardiol Clin. November 1st, 2017;35(4):615–22.
VIII. Isiguzo G, Du Bruyn E, Howlett P, Ntsekhe M. Diagnosis and Management of Tuberculous Pericarditis: What Is New? Curr Cardiol Rep. January 15, 2020;22(1):2.
IX. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. May 1st, 2013;18(3):367–73.
X. Sengupta PP, Eleid MF, Khandheria BK. Constrictive Pericarditis. Circ J. 2008;72(10):1555–62.
XI. Noubiap JJ, Agbor VN, Ndoadoumgue AL, Nkeck JR, Kamguia A, Nyaga UF, et al. Epidemiology of pericardial diseases in Africa: a systematic scoping review. Heart. February 1st, 2019;105(3):180–8.
XII. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous Pericarditis. Circulation. December 6, 2005;112(23):3608–16.
XIII. Secretaría de Salud. NORMA Oficial Mexicana NOM-006-SSA2-2013, Para la prevención y control de la tuberculosis. [Internet]. 2013. Available in: https://dof.gob.mx/nota_detalle.php?codigo=5321934&fecha=13/11/2013#gsc.tab=0
XIV. Xie DL, Cheng B, Sheng Y, Jin J. Diagnostic accuracy of adenosine deaminase for tuberculous pericarditis: a meta-analysis. Eur Rev Med Pharmacol Sci. November, 2015;19(22):4411–8.
XV. Reuter H, Burgess LJ, Schneider J, Van Vuuren W, Doubell AF. The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology. 2006;48(3):295–302.
XVI. Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, et al. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. August 27, 2018;2018(8):CD012768.
XVII. Sagristà-Sauleda, J, Almenar Bonet, Ferrer, Juan Angel, Bardaji Ruiz, Alfredo, Bosch Genover, Xavier, Soldevila, Jose Guindo, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en patología pericárdica. 2000;(53):394–412.
XVIII. Merino A, Marín JL. CITOLOGÍA Y BIOQUÍMICA DE LOS LÍQUIDOS BIOLÓGICOS. 2017;(28):112–35.
XIX. Carreto NAC, Fraga MT, Chon OG, López SG. Introducción a la fisiología pericárdica. 2005;12(3):154–64.
XX. Padilla Osvaldo, Abadie Jude. Pruebas de líquido cefalorraquídeo (LCR): valores normales - Recursos [Internet]. Manual MSD versión para profesionales. 2021 [Cited on may 11, 2023]. Available in: https://www.msdmanuals.com/es-mx/professional/recursos/valores-normales-de-laboratorio/an%C3%A1lisis-del-lcr-valores-normales